![]() |
Boosting the body’s own defense system has proven to be a particularly effective therapy for skin cancer. Photo credit: National Cancer Institute |
The artificial intelligence model could be utilized to enable more effective care for skin cancer patients and could lead to similar breakthroughs in the diagnosis and treatment of other cancers.
Researchers from the University of Helsinki, HUS Comprehensive Cancer Center, Aalto University and Stanford University have developed an artificial intelligence model that predicts which skin cancer patients will benefit from a treatment that activates the immune defense system. In practice, the AI model makes it possible to diagnose skin cancer with a blood test, determine the prognosis and target therapies increasingly accurately.
The skin cancer–related study was published in the esteemed Nature Communications journal.
The right medication for the right patient
Boosting the body’s own defense system has proven to be a particularly effective therapy for skin cancer. The problem with therapies that activate the immune system are the differences between patient groups: while some patients can be said to be cured, others gain no benefit from the treatment at all.
“Prior research has been unable to provide doctors with tools that would predict who will benefit from treatment that activates the defense system. The correct targeting of therapies is extremely important, since drug therapies are expensive and serious adverse effects fairly common,” says doctor and Doctoral Researcher Jani Huuhtanen from the University of Helsinki and Aalto University.